TransMedics, Inc. Secures $36 Million Round of Financing

TransMedics, Inc. Secures $36 Million Round of Financing

November 27, 2012

— /PRNewswire/ -- TransMedics, Inc., the global leader in organ preservation technology, announced the closing of a $36 million financing round led by Abrams Capital with the participation of existing investors including Flagship Ventures, Hercules Technology Growth Capital and Kleiner Perkins Caufield & Byers.

bioMérieux and Quanterix Sign Strategic Partnership in Ultrasensitive and Multiplex Immunoassays

bioMérieux and Quanterix Sign Strategic Partnership in Ultrasensitive and Multiplex Immunoassays

November 15, 2012

Marcy l’Etoile (France) and Lexington, MA (U.S.) – November 15, 2012bioMérieux and Quanterix announced today that they have entered into a strategic agreement that gives bioMérieux worldwide exclusive rights to Quanterix’s Simoa technology in clinical laboratories and for industrial applications. Under the agreement, Quanterix will deliver a new instrument and consumables based on its Simoa technology. bioMérieux will develop ultra-sensitive and multiplex assays on the platform.

T2 Biosystems Announces Issuance of Patents Covering T2MR Direct Detection Technology

T2 Biosystems Announces Issuance of Patents Covering T2MR Direct Detection Technology

November 14, 2012

LEXINGTON, Mass., Nov 14, 2012 (BUSINESS WIRE) -- T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued two patents adding depth and breadth to the Company's intellectual property portfolio. These patents cover both the device and methods related to the Company's flagship T2Candida assay and the detection of additional biological analytes, including specific drug and biomarker targets, in biological samples using the T2MR platform.

Affinnova Ranked Number 274 Fastest Growing Company in North America on Deloitte’s 2012 Technology Fast 500™

Affinnova Ranked Number 274 Fastest Growing Company in North America on Deloitte’s 2012 Technology Fast 500™

November 14, 2012

WALTHAM, MA, USA (November 14, 2012) – Affinnova, Inc., the global leader in innovation software and services, today announced it ranked 274 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Affinnova grew 279 percent during this period.

Joule, LS9, Mascoma, Novomer and Oasys named to AlwaysOn's 2012 GoingGreen Global 200 Top Private Companies

Joule, LS9, Mascoma, Novomer and Oasys named to AlwaysOn's 2012 GoingGreen Global 200 Top Private Companies

November 13, 2012

This year's 200 top, private greentech companies -- plus 30 to watch -- are taking maturing greentech research and pairing it with innovative technology solutions to change the way we live our lives for the better.

AlwaysOn is proud to announce the sixth annual GoingGreen Global 200-the top companies that are disrupting global industries and creating viable business models for the green technology marketplace.

BG Medicine Reports Third Quarter 2012 Financial Results and Provides Business Update

BG Medicine Reports Third Quarter 2012 Financial Results and Provides Business Update

November 13, 2012

WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD) today reported financial results for the third quarter ended September 30, 2012 and provided a business update.

BG Medicine Outlines New Commercial Strategy

BG Medicine Outlines New Commercial Strategy

November 13, 2012

WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today provided an update on its new commercial strategy to speed the adoption of its cardiovascular diagnostic tests -- the BGM Galectin-3(R) test and the CardioSCORETM test.

BG Medicine Announces Data Analyses Presented at American Heart Association Meeting

BG Medicine Announces Data Analyses Presented at American Heart Association Meeting

November 9, 2012

WALTHAM, Mass., Nov 9, 2012 (GlobeNewswire via COMTEX) -- BG Medicine Inc., a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that results of retrospective analyses of the BioImage Study cohort were presented this week at the American Heart Association (AHA) Scientific Sessions 2012 in Los Angeles. These presentations resulted from research sponsored by the company and included data on the CardioSCORE(TM) test, a proprietary blood test currently being developed by the company.

Visterra Secures Financing from Gates Foundation and Omega to Close $26M Series A Financing

Visterra Secures Financing from Gates Foundation and Omega to Close $26M Series A Financing

November 9, 2012

New investors join existing investors to expand Series A with $13M in new funding

The Boston Globe Names Black Duck a Top Place To Work in 2012

The Boston Globe Names Black Duck a Top Place To Work in 2012

November 5, 2012

BURLINGTON, MA, November 5, 2012 – Black Duck, the trusted partner for open source software adoption, management and governance, has been named a Top Place to Work in Massachusetts in the 2012 employee-based survey from The Boston Globe.